Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 Jun;14(6):502-5.
doi: 10.1007/BF02616090.

An improved syncytia infectivity assay for the bovine leukemia virus

An improved syncytia infectivity assay for the bovine leukemia virus

C A Diglio et al. In Vitro. 1978 Jun.

Abstract

Several factors that influence the sensitivity of the syncytia infectivity assay for the bovine leukemia virus (BLV) and BLV-infected lymphocytes have been examined. The use of early-passage indicator bovine embryonic spleen (BESP) cells and their pretreatment with diethylamino-ethyl-dextran (DEAE-D) was essential for optimal sensitivity. Polybrene was less effective than DEAE-D. The combination of DEAE-D and polybrene was more effective than DEAE-D alone when BLV-infected leukocytes were used as the inoculum, but not when the inoculum was a cell-free BLV preparation. Using BESP cell passages 4 to 11 as indicators, reproducible titers were obtained when aliquots of the same virus stock were assayed at different times after freezer storage. When assaying peripheral blood lymphocytes from infected cattle, optimal syncytia responses were observed consistently by inoculating 5 X 10(6) viable lymphocytes per 60-mm Falcon dish. Centrifugation of peripheral blood leukocytes from BLV-infected cattle in discontinuous bovine serum albumin gradients can be used to separate a subpopulation of infected lymphocytes. Use of this subpopulation as the inoculum, rather than unseparated buffy-coat leukocytes, greatly increases the sensitivity of the syncytia infectivity assay.

PubMed Disclaimer

Similar articles

References

    1. Cancer Res. 1976 Mar;36(3):1068-73 - PubMed
    1. Cancer Res. 1974 Apr;34(4):893-900 - PubMed
    1. Cancer Res. 1976 Mar;36(3):1056-67 - PubMed
    1. J Natl Cancer Inst. 1972 Apr;48(4):985-96 - PubMed
    1. Virology. 1969 Jul;38(3):414-26 - PubMed

Publication types